BRD4 modulates vulnerability of triple-negative breast cancer to targeting of integrin-dependent signaling pathways. - Zhang, Yang; Xu, Bingwei; Shi, Junfeng; Li, Jieming; Lu, Xinlan; Xu, Li; Yang, Helen; Hamad, Nevean; Wang, Chi; Napier, Dana; He, Shuixiang; Liu, Chunming; et al. (Cellular Oncology (2211-3428), 2020)